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1. Introduction 
The perfect cardiac catheterization technique, including good diagnostic and therapeutic 
qualities, without risk and with no recovery time for the patient, does not exist. Obtaining 
initial access to the arterial circulation is the first and most frequent catheterization difficulty 
encountered by the interventional cardiologist during the procedure. Often, it is also the 
only difficult part of the exam for the patient because it may cause a vagal reaction or 
painful spasm. These procedural problems inevitably increase catheterization time and are 
sometimes the underlying causes of more significant complications. Arterial access is a 
crucial step of percutaneous cardiac procedures and therefore requires special attention. 
Today, percutaneous coronary intervention (PCI) are usually performed via the femoral or 
radial arteries (a brachial approach may occasionally be required as third choice vascular 
access).  Since the first demonstration of transradial approach feasibility in 1989, by Lucien 
Campeau, many studies have confirmed this initial experience and especially its safety and 
performances compared to transfemoral route. Nevertheless, a recent study reports that less 
than 2% of percutaneous coronary interventions were performed by a transradial approach 
in the United States between 2004 and 2007(1). The persistent discrepancy between current 
practice in vascular access site choice and known advantages of a radial access needs to be 
clarified, enlightened by recent data. 
2. Short overview of complications related to arterial access site choice for 
PCI 
Over the last three decades, advances in percutaneous coronary interventions techniques 
and contemporary pharmacotherapy have made these procedures safer and more reliable in 
a wide range of patients, often older and sicker than before. 
2.1 Bleeding after percutaneous coronary interventions 
In routine clinical practice, bleeding complications are a frequent non-cardiac outcome of 
therapy for acute coronary syndromes even in the case of an adequate arterial puncture 
technique. Aggressive antithrombotic regimens used in this setting even if highly powerful 
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in reducing ischemic events, also expose patients to a higher rate of bleeding (related or not 
to the vascular access site). 
More than two thirds of all bleeding complications involve the arterial access site and range 
from a local non significant hematoma to life-threatening bleeding (Fig. 1). The most 
common origins of bleedings not related to arterial access are gastrointestinal followed by 
cardiac tamponade and intracranial haemorrhage (2,3). 
Retroperitoneal haemorrhage is more difficult to classify because of its double potential 
aetiology (often linked to manipulations related to a femoral approach but rarely occurring 
spontaneously in the case of anticoagulation and/or antiplatelet therapy). Retroperitoneal 
bleeding leading to a major bleed is reported to occur in approximately 0.1% to 0.3% of 
patient treated by a femoral access but is maybe an underestimate (2,4). 
Risk factors for such complications are now well identified and could be divided in four 
categories (see Table 1).  
 
Clinical Factors  - Advanced age 
- Female gender 
- Low body weight/obesity  
- Prior bleeding 
- Severe hypertension  
- Heart failure 
- Peripheral vascular disease  
- Acute coronary syndrome  
Biochemical Factors  - Renal insufficiency 
- Anemia  
- Diabetes 
Procedural Variations  - Femoral Access (versus Radial Access) 
- Increased sheath /Catheter size  
- Prolonged sheath time after procedure  
- Intra aortic Balloon Pump 
- Concomitant venous sheath  
- Need for repeat intervention  
Treatment Combinations  - Antiplatelet therapy (dosage, efficacy, timing, duration) 
- Overdose of anticoagulants (+/- GP IIb/IIIa inhibitors) 
- Crossover / combinations of anticoagulants  
-Thrombolytic agents  
Table 1. Factors associated with a higher bleeding risk (5-10) 
Large randomized trials and registries with “real world” populations of patients have 
clearly identified clinical characteristics conferring a higher risk of bleeding: advanced age, 
female gender, obesity, low body weight, chronic renal disease, peripheral vascular disease 
and a previous history of bleeding. Procedural predictors for an increased bleeding risk 
include faulty puncture technique, sheath size, prolonged sheath time, use of glycoprotein 
(GP) IIb/IIIa inhibitors, vascular closure devices, intensity/duration of anticoagulation with 
heparin, but also vascular access strategy using femoral rather than radial artery(3,9,11-17). 
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The main difficulty encountered when comparing trials which study the true incidence of 
haemorrhagic events linked to vascular access options remains the lack of a precise 
definition for this complication (18-20) or at least of a consensus taking into account main 
parameters in order to establish a bleeding severity score (clear identification of bleeding 
site, haematocrit /haemoglobin drop, hemodynamic consequences, treatments required…). 
Even if some authors (21) report a significant reduction in the incidence of major femoral 
bleeding complications over time (from 8.4 % in 1995 to 3.5 % in 2005), the single effective 
way to reduce majors bleeding related to a coronary angiography or intervention procedure, 
according to recent data, is to use radial access (2,11,22-24). In experts hands, this strategy 
allows a 50 to 75 % reduction in major bleeding events (24) with the greatest absolute benefit 
for obese patients and in the setting of acute myocardial infarction (primary or rescue 
coronary angioplasty). Therefore, radial access should be promoted as the preferential 
access site for percutaneous coronary interventions. Nevertheless the keys to preventing 
bleeding complications are well known: good knowledge and recognition of predisposing 
factors, meticulous examination of the access site before the puncture follow by a careful 
sheath placement in the artery without forceful manoeuvre and discontinuation of heparin 
at the end of the procedure. 
  
Fig. 1. Large right groin and forearm hematomas. 
2.2 Other frequent complications related to arterial access site  
Other significant access site related complications encountered after a catheterization 
procedure are pseudoaneurysm, arterio-venous fistula, femoral laceration, femoral 
thrombosis with or without distal embolization, and any need for a surgical exploration or 
repair. Less frequently groin infection (puncture site abscess), neural damage and venous 
thrombosis are observed. 
2.2.1 Pseudonaneurysm 
A pseudoaneurysm is defined as an encapsulated hematoma or cavity (contained by 
surrounding tissues) communicating with the lumen of an artery because of a localized 
disruption of the media (Fig. 2). It mainly occurs after an inadequate artery compression 
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following sheath withdrawal. Predisposing factors for this iatrogenic arterial trauma are 
impaired hemostasis and factors known to be associated with difficult and prolonged 
procedures (peripheral vascular disease, large sheath use, aggressive anticoagulation 
and/or fibrinolytic therapy, prolonged sheath and anticoagulation times) and in case of a 
femoral approach the concomitant use of an intra aortic balloon pump and an early 
ambulation after catheterization. The reported incidence for femoral access seems to be 
around 1% (maybe higher), and is lower in the case of radial access (≤ 0.2 %) (2,25-28). 
An adequate recognition of this complication, which may occur more than one year after the 
catheterization procedure, is mandatory because of the risk of rupture estimated at 
approximately 4 % for large pseudoaneurysms (> 3cm) (29-31). 
 
Fig. 2. Pseudoaneurysm of the radial artery (2D color-Doppler flow imaging) 
2.2.2 Arteriovenous fistula 
An arteriovenous fistula results from an overlying vein puncture during femoral artery 
catheterization, creating a communication between the two vessels after sheath removal. A 
high velocity and continuous jet originating from the artery and going into the vein lumen, 
is often easily demonstrated by color flow Doppler examination if clinical manifestations 
exist at the access site. The reported incidence is low in recent trials studying patients after a 
coronary angiography or intervention by femoral approach (0.1-2.2%) and extremely rare for 
radial approach (< 0.1%) (2,4,26). 
By femoral approach, the occurrence of arteriovenous fistula and pseudonaneurysm is 
reported to be significantly higher if the puncture site is located distal to the division of the 
deep and superficial femoral arteries (25). 
2.2.3 Arterial wall dissection  
Arterial wall dissection is probably frequently unrecognized especially in cases of local 
dissection although its true incidence is hard to establish. Regarding published and already 
historical data for recognized dissection, the incidence of this arterial wall injury varies from 
0.01% to 0.5% (32,33). However, when considering the fact that, as demonstrated by 
angiographic studies, 25% of patients admitted for a catheterization procedure had common 
femoral artery atherosclerotic plaques determining at least a 20 % stenosis, it is easy to 
understand that all intravascular foreign body as a needle or catheter may easily deflect off 
some of these plaques. 
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2.2.4 Arterial thrombosis 
Due to the increasing number of percutaneous cardiac procedures performed annually and 
to the worldwide operator preference for this vascular access, most arterial thromboses 
occur in the common femoral artery. Nevertheless the incidence of this serious adverse 
event remains very low after coronary intervention (<0.5%) probably because of the 
widespread use of high dose multi-drug antithrombotic therapy for percutaneous 
interventions (2,4).  
The common femoral artery being the unique blood supply to the leg, an urgent diagnostic 
of this complication followed by immediate heparinization and mechanical or surgical 
thrombectomy are usually required. On the contrary, radial artery thrombosis is a relatively 
frequent asymptomatic condition (incidence: 3-6 %). It is a benign issue, with nearly no 
clinical sequelae observed after occlusion of this vessel, because of the double blood supply 
to the hand insured by the palmar arch. Many of these radial occlusions (40-60%) are 
spontaneously recanalized after one month (11,34). This specific point will be discussed later 
in the chapter. 
2.3 Impact of vascular closure devices on vascular access site complications  
Today, closure devices are widely used to obtain a rapid hemostasis after percutaneous 
transfemoral approach but their safety remains largely controversial. Marginal evidences 
concerning the effectiveness of these devices are derived from pooled analyses of a 
heterogeneous group of small randomized trials, many of poor methodological quality 
(26,35). 
All of the approved arterial closure devices have proven their efficacy in obtaining 
immediate hemostasis after sheath removal, in allowing early ambulation, and in improving 
patient comfort (36). However, there is no report showing a clear reduction of access site 
complications related to their use (compared to efficacy of manual compression) especially 
after diagnostic angiography. In the setting of percutaneous coronary interventions, meta-
analysis of randomized trials only showed a trend towards less access site related 
complications with some of these devices but also an increased risk with others (26,35). 
Additionally, four separate prospective studies have found that bleeding complications 
were more frequent with transfemoral access and closure device than with transradial access 
(up to 3.7% versus less than 0.7%, respectively) (37-40).  
There are still matters of concern about the use of these devices. For example they may 
increase the risk of hematoma and pseudoaneurysm formation (26,35,36,41-43). Moreover, 
early device failure rates and their impact on vascular access site complications are not 
always clearly reported in these trials but may decrease after the initial learning curve. 
Recently, data with the last generation of vascular closure devices suggest that their use may 
decrease vascular complications but these points had to be confirmed once again by large 
randomized trials because it maybe simply reflects a better patient selection and operator 
experience with these devices over time (4,42,44). 
When an arteriotomy closure device is used, some specific complications may occur in 
addition to those previously described for manual compression. A higher rate of access site 
infections (0.3% versus 0.05 % with manual compression) and more episodes of acute or late 
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limb ischemia (0.4% versus 0.1% for manual compression) are reported. The need for 
surgery, in case of device failure, is not commonly reported with details in the great 
majority of previous published trials. Nevertheless, surgery for partial embolization, to 
remove trapped components of these devices or after vessel laceration is uncommon(4,35). 
Given the remaining uncertainty about their true impact on vascular complications and the 
difficulty to assess costs induced by specific vascular access complications, the widespread 
adoption of these devices following endovascular interventions is still controversial and 
needs to be clarified in the future (4,45). 
2.4 Conclusions  
All vascular access techniques, even if perfectly handled by the interventional cardiologist 
are linked with a minimal but inevitable rate of complications arising because materials 
enter atherosclerotic vessels. To avoid more serious clinical consequences for the patients, it 
is particularly important to give meticulous attention to the access site not only before the 
puncture but also in the hours following the procedure and to recognize predisposing 
factors for such complications. 
3. Anatomical considerations and technical aspects of a transradial approach 
3.1 Favorable anatomical characteristics of the radial artery  
Differences observed in terms of vascular complications after radial and femoral 
percutaneous interventions are mainly based on favorable anatomical characteristics of 
the radial artery (compared to those describe for the common femoral artery) (Table 2 and 
Fig. 3).  
 
 
Fig. 3. Landmarks for vascular access (48,50,51) 
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Common Femoral Artery (CFA) Radial Artery (RA) 
CFA is relatively deep. 
• The ideal site of puncture may be hard 
to identify especially in obese patients.  
• The inguinal crease is an unreliable 
landmark in more than two thirds of 
patients. 
• The strongest femoral pulse correctly 
identified the mid-CFA in 90 % of cases  
Distal RA had a superficial course, 
• This artery is easy to palpate even in 
obese patients 
• At the level of the puncture site, the 
artery lies just under skin and fascias 
  
Puncture site is over the hip joint  
• The most reliable landmark is probably 
the junction between the middle and the 
lower third of the femoral head 
(radiographic landmark) 
Puncture site is not over a joint  
• The most reliable landmark is ideally 
2-3 cm proximal to the flexor crease 
of the wrist (clinical landmark) 
Compression of the CFA may be hard  
• No hard and fixed structures behind the 
artery 
RA can easily be compressed with 
minimal pressure  
• At the puncture site, radial bone is 
just beneath the artery  
CFA lies just near a major vein (Femoral 
Vein) and nerve (Femoral Nerve) 
RA is separated from median nerve and 
major veins  
CFA is the unique blood supply to the leg  Double blood supply to the hand insured 
by the palmar arch 
Table 2. Comparison of access site characteristics (46-48) 
Its superficial course makes this artery easily accessible to puncture and, after the procedure, 
more amenable to compression (because of bone support beneath), even in obese patients. 
The puncture site is not over a joint, so compression devices are always stable and effective 
to ensure good hemostasis after sheath removal. Also wrist movements are not impaired 
after a transradial percutaneous intervention, which facilitates rapid recovery and makes an 
outpatient strategy feasible. Moreover, the radial artery is separated from median nerve and 
major veins of the forearm making post-catheter injuries of these structures rare. Lastly, the 
double blood supply to the hand makes hand ischemia an almost impossible complication if 
the presence of functional collaterals between the radial and the ulnar arteries, as judged by 
the Modified Allen’s Test (49) or alternative tests, has been assessed. 
3.2 Learning curve and prerequisite conditions for a safe technique conversion 
The same catheterization laboratory set up and patient preparation as for femoral 
procedures can be used for the radial approach and only minor adaptations to improve 
patient and operator comfort, especially for the puncture, are required. A good arm support 
system is the only inescapable element needed and a pulse oximeter (finger 
plethysmography) may be required to perform alternative tests in case of an abnormal 
modified Allen’s test (50,51).  
Transradial access is known to be technically more demanding and time consuming, 
especially during the early learning curve (52).  
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The small caliber (2-3.5 mm in diameter) and the alpha–adrenergic innervations of the artery 
make the puncture task the key point of a successful transradial procedure.  
When the accurate site of puncture has been correctly identified, the most critical step of the 
radial catheterization procedure begins. Different puncture techniques exist but the most 
commonly used today by experienced radial operators is the over-the-needle technique 
(50,51). 
As described in many papers dedicated to transradial approach (53) puncture remains, for 
beginners, the cornerstone of the learning curve and it takes time to develop all the skills 
required, even for experienced interventionalists. Obtaining arterial access by a single or a 
limited number of puncture attempts is probably the best way to avoid difficulties linked to 
a refractory spasm following a difficult puncture. 
This is the reason why, it is strongly recommended to take extra time to prepare and realize 
the puncture and to keep in mind that gentle and cautious manipulations will always pay 
off later. Failure of the puncture task (inability to puncture or to wire the artery) accounts for 
more than 50 % of transradial approach failures. Even if it takes approximately 200-300 cases 
to overcome initial difficulties, several studies confirms the reality of a long learning curve 
(53). During the beginner’s phase of radial access experience, good patient selection with a 
readily palpable radial pulse is necessary to help perfect all the skills needed for this elegant 
technique. Weak radial pulses, small radial arteries, old patients, patients with known 
peripheral vascular disease or post CABG surgery should be avoided at this time. All these 
elements, required to identify patients with the most difficult access, are given by the 
bedside clinical evaluation of the patient, even if puncture is frequently less difficult than 
anticipated. 
During the procedure, inability to cross forearm, arm or intra thoracic vasculature 
difficulties accounts for 10 % of transradial approach failures, inability to reach a coronary 
or graft ostia due to difficulties in rotating and manipulating the catheters for 10% and the 
remaining failures are related to the inability to reach a contra-lateral mammary graft.   
An access site crossover, related to failure of initial strategy, is required in 6-7% of 
transradial procedures compared to less than 2% in case of femoral approach (including PCI 
procedures). For high volume radial operators or centers, lower crossover rates are reported 
(4-6%) (2,11,24,53). Once again, these data confirm the importance of experience and 
expertise when interventionalists are dealing with this approach. 
In these conditions, with growing experience and state of the art materials, and if there is a 
systematic use of the contra-lateral radial artery in case of puncture failure on the initial side 
(the same technique is applied for femoral access) a very high success rate can be expected 
by this technique, approximately 98 % or more, with no significant differences among 
subgroups of patients (53). 
After a while, when experience and confidence in the technique has grown, more adequate 
catheter choice and skills in their manipulations will ensure similar clinical results as in the 
femoral approach (2,11). 
Indeed, PCI success rate is similar for the two approaches. The RIVAL study, the largest 
randomized trial comparing radial and femoral access for acute coronary syndromes, 
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demonstrates the equivalence of the two techniques in terms of complications at the level of 
the coronary tree (2). The number of guiding catheters required for the procedure, the rate of 
abrupt coronary closure, no reflow, dissection with reduced flow, perforation, catheter 
thrombus and stent thrombosis were similar in the two arms of the study. These 
observations had already emerged from the meta-analysis performed by Agostoni in 2004 
(11), which did not show statistically significant differences in terms of procedural failure 
for studies performed after 1999. Similarly, no differences were shown in PCI procedural 
time and contrast volumes used for the procedures. 
3.3 Difficult cases by transradial approach and limits of the technique 
Transradial approach is considered to be a difficult approach, first because of the puncture 
task but also for the frequent occurrence of spasm, difficult catheter selection or inability to 
overcome difficult radial or vascular anatomy, especially during the learning curve. 
Spasm is usually related to prolonged or excessive catheter manipulation but may already 
occur during puncture or after sheath insertion. By using adequate doses of spasmolytic drugs 
(intra-arterial verapamil) at the beginning and during the procedure and small catheter size (5 
French), refractory spasm becomes rare (1,1% versus 4,8% with 6 French catheters) (54). 
Interestingly, spasm more frequently occurs where difficulties are encountered in advancing 
the wire or the catheter and not only at the level of the radial artery (it can also be seen at the 
level of the upper limb or of the brachio-cephalic trunk). For experienced radial operators, 
spasm is not reported as a pertinent cause of radial approach failure during percutaneous 
coronary interventions (11,53). However, when resistance occurs, it is strongly recommended 
to perform an angiogram to adequately define the anatomy, spasm level or rarely stenosis or 
occlusion levels. Several studies have shown that intra-arterial verapamil and nitroglycerine 
are the most effective medications to prevent or to relieve spasms. Moreover, selective 
angiograms of the left and right coronary arteries (as well as left ventriculography) are 
possible with only one catheter by transradial approach (Optitorque TIG™ catheter, Terumo 
corp.). Thus, there should not be a need for three different catheter exchanges, which also 
helps in reducing the occurrence of spasm. In the same way, sheath-induced spasms are 
minimized and far less frequent when hydrophilic-coated materials are used. Hydrophilic 
coating also helps to reduce patient discomfort and facilitates sheath withdrawal (55). Finally, 
a higher incidence of radial artery thrombosis is documented in patients with periprocedural 
spasm (56).  
Beginners frequently evoke loops, tortuosities and anatomic variants as one other major 
hurdle to overcome during learning curve. These unpredictable abnormalities are quite rare 
in current practice but the most challenging ones may require an alternative vascular access 
site. Tips and tricks, state of the art materials (especially hydrophilic wire and 0.014” PTCA 
guidewires) are helpful in overcoming these difficulties in a large majority of these cases. 
Solutions that work are often those associated with gentle wire and catheter manipulations 
in order to prevent vascular injury and perforation.  
Another frequently advanced argument against transradial intervention is inadequate 
guiding support. Randomized trials performed after 2000 do not advocate this point when 
procedural success is compared to those reported for transfemoral PCI studies, especially 
when dedicated radial materials are used (2,11,37,57). Most radial arteries have a lumen 
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large enough to accommodate 6 French catheters and some large radial arteries are able to 
eventually accept 7 French catheters or larger, but these sizes are not often required. 
Large lumen 6 French guiding catheters with dedicated radial shapes give good back up 
support and allow to perform a wide range of the most complex intracoronary procedures 
(ostial or bifurcation lesions, left main stenosis, chronic total occlusions, thrombectomy, 
rotational atherectomy, saphenous vein graft lesions, acute coronary syndromes and ST-
elevation myocardial infarction) (2,58-63) but standard curves designed for femoral 
approach also work well in most cases. 
Nevertheless, in routine clinical practice, 5 French guiding catheters make direct stenting 
easily feasible in the great majority of procedures. In a randomized comparison study, 
Dahm had even shown a trend in favor of the superiority of 5 French guiding catheters over 
6 French guiding catheters in terms of procedural (95.4 versus 92.9 %, p =0,097) and 
clinical success (93.1 versus 90.5 %, p=0,097) (54).On the other hand, today, with larger 
sheathless guiding catheter technology, coronary techniques only accessible by a femoral 
way are far less numerous than before (64,65). For example, sheathless 7.5 French guiding 
catheters open the way for the most complex PCI techniques, in nearly all patients, by 
transradial approach but had smaller outer diameters than 6 French radial introducer 
sheaths.  
As with the femoral approach, the ideal sizing and shape of guiding catheters is still, and 
will stay a matter for debate. 
The side to choose for the first radial approach in a given patient also remains a 
controversial issue with no clear answer. In most centers, transradial coronary interventions 
are performed through the right radial artery, because this side offers a more comfortable 
working position for the operator, but on a technical point of view there is some evidence 
that catheter manipulation could be easier by a left-sided approach, because of similar 
sensations compared to a femoral way and perhaps offering more back-up support for 
guiding catheters. In the TALENT study, a randomized comparison of right versus left 
radial approach for diagnostic procedures, the left approach was associated with lower 
fluoroscopy time and radiation dose, reflecting an easier procedure, particularly in older 
patients (> 70 years) and for operators in training (66). The absence of a radial artery pulse 
or a negative Modified Allen’s Test on one side, as well as the need to selectively cannulate a 
mammary bypass graft also frequently influence the choice. Today, long catheters allow 
to easily reach the infradiaphragmatic arterial system (renal, mesenteric, iliac, femoral or 
lower limb arteries but also for example a gastro-epiploic bypass graft). If these catheters 
are not available, a left radial approach saves ten centimeters of catheter length (by this 
route, catheters do not cross the arch of aorta).Similarly, the cerebrovascular pathology 
(carotid and vertebral arteries) can be imaged and eventually treated by transradial 
approach. 
In routine clinical practice, the control of bypass grafts is also a frequent request. 
Angiography of the left internal mammary artery is easy to perform by the left radial 
approach (as for a right internal mammary artery by the right radial approach). In case of a 
bilateral mammary artery bypass graft, a right radial approach should be preferred but left 
internal mammary artery opacification by the right radial remains challenging even for 
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skilled operators (53,67). A successful selective opacification of the contra-lateral mammary 
artery can be expected in 50% of these particular cases if performed by an experienced 
operator using dedicated catheters (53).In our institution, we mainly use for this purpose the 
Outlook™ 4 French diagnostic catheter (Terumo corp.).To reach saphenous vein grafts, 
either left or right radial approaches can be chosen, with a similar success rate using 
standard catheter curves (63). Sometimes, a bilateral radial approach, during the same 
procedure, is necessary to obtain adequate images of the grafts. 
Finally, there are only a few relative contraindications to a transradial approach: patients 
with a negative Allen test in both hands, patients with end-stage renal disease (just before 
the creation of an arteriovenous fistula for haemodialysis) and patients with known severe 
obstructive atherosclerotic disease at the level of the innominate, subclavian or upper limb 
arteries. Finally, some patients may have had previous coronary artery bypass surgery using 
a radial artery as a conduit which precludes radial access by this side. 
3.4 Conclusions 
One challenge encountered with radial access is the steep learning curve, but this hurdle can 
be more easily overcome by following an educational program dedicated to this approach 
and addressed to interventionalists and fellows in training. The widespread diffusion of the 
technique in teaching centers as well as the growing interest of major cardiovascular 
societies and device industry for this approach will also progressively ensure its greater 
penetration in the interventional cardiologists’ community. 
4. Specific complications of transradial approach  
Despite a proven safety profile leading to a drastic reduction of vascular access site 
bleeding, the transradial approach is not totally free of complications. Catheterizers must be 
aware of some rare complications, which are often minor and localized if recognized 
without any delay. 
4.1 Post procedural radial artery thrombosis: The main pitfall of transradial approach? 
Although radial artery thrombosis is still a matter of concern after a transradial approach, 
this complication is usually benign because of the double blood supply to the hand insured 
by the two forearm arteries inter-connected at the level of the palmar arch. Moreover, hand-
threatening ischemia, with necrosis or clinical sequelae, has not been reported after a 
transradial procedure to this day. 
As shown by studies that have planned post catheterization Doppler ultrasound 
examinations, the incidence of radial artery thrombosis ranges, in general, from 3% to 6% 
but one study reports a rate of 9.5% (34,56,68-71). A loss of radial pulse is reported in up to 
9% of patients in other studies. 
The occlusion rate increases with the size of catheters used for the procedure (54,72) and is 
more precisely related to the ratio between the inner radial artery diameter and the sheath 
outer diameter (73) . The incidence of occlusion is 4% if the ratio is higher than 1 and rises 
dramatically to 13% in patients with a ratio of less than 1. 
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Other factors have been found to affect occlusion rate. Repeat cannulation (74) and older age 
are known to be predisposing factors but heparinization is effective in reducing its 
occurrence as well as the use of hydrophilic materials. For transradial procedure, adequate 
anticoagulation is extremely important and should be immediately started in all patients 
after sheath insertion; at least 5000 units of intra-arterial heparin are recommended. In 
patients receiving only 1000 units for a diagnostic coronary angiography, the incidence of 
radial occlusion climbs up to 30% (34). Intra-arterial or intravenous heparin administration 
provide comparable efficacy in preventing radial artery occlusion (75). 
Nearly 50% of the patients in whom the radial artery is shown occluded at hospital 
discharge may expect a spontaneous recanalization of the vessel in the first month after 
procedure. Therefore, the true definitive incidence of radial artery thrombosis is probably 
between 2 and 3% (34).  
Short procedure duration and immediate sheath removal at the end of the procedure, 
whatever the dose of heparin or the use of GP IIbIIa inhibitors, also contribute in 
maintaining radial permeability. In the same way, it seems to be relevant to avoid prolonged 
post-procedure compression times, especially if a mechanical device applying high 
pressures is used. Moreover, with some of these compression devices, a fine pressure 
adjustment, in order to always maintain blood flow in the radial artery during the 
compression, is feasible and may contribute to radial artery protection (76). In the PROPHET 
trial, guided compression that allowed antegrade flow, using the Barbeau’s test to document 
radial artery patency at time of hemostasis, was shown to be highly effective in preventing 
radial artery occlusion (incidence decreased by 75% at 30 days after radial access) when 
compared to usual care (1.8% versus 7%, p<0.05) (77).  
Nevertheless, even if radial occlusion is a fairly infrequent outcome of transradial approach, 
the radial artery patency should be checked in all patients after the procedure. Bernat et al. 
have shown recently that an early and short (1-hour) ipsilateral ulnar artery compression 
using TR band™ (Terumo corp.) could be an effective and safe non-pharmacologic method 
for the treatment of acute radial artery occlusion (78). 
4.2 Post-procedural non-occlusive radial artery injury 
As demonstrated by several studies, permanent radial artery damage without occlusion 
may sometimes follow transradial procedure.  
In a first study, ultrasound examinations of the radial artery showed no significant 
difference in the mean radial artery internal diameter between pre and early post-procedure 
measurements (at 1 day). Conversely, after a mean follow up of 4.5 months, internal 
diameter significantly decreased from 2.63 ± 0.35 to 2.51 ± 0.29 mm (p = 0.01). Moreover the 
mean radial artery diameter was smaller and the radial occlusion rate higher (2.6% versus 
0%; p = 0.01) in patients undergoing repeat transradial approach as compared to a first-time 
procedure (79). 
Further intravascular ultrasound (IVUS) studies have explained that this progressive 
narrowing is secondary to an intima-media thickening (hyperplasia), especially in the distal 
radial artery, presumably induced by trauma from sheath or catheter insertion (80,81). 
Sanmartin et al. reported that soon after a transradial catheterization the vasoreactivity is 
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impaired, but generally recovers as early as 1 month after the procedure (82). Edmunson et 
al. have also demonstrated that the vessel vasoreactivity was maintained despite the fact 
that post procedural non occlusive radial artery injury was a quiet common observation 
after transradial interventions (80). Therefore, the main underlying process of this 
permanent arterial wall injury is certainly catheter-based. 
4.3 Forearm hematoma  
Radial artery perforation, if not early recognized and managed, can lead to severe forearm 
hematoma and compartment syndrome. Prompt detection of the complication and precise 
localization of the bleeding source are of prime importance to adequately manage the 
problem with a pressure bandage dressing or a blood pressure sphygmomanometer inflated 
just over systolic pressure and placed over the bleeding area (83,84). In the great majority of 
cases this maneuver permits an easy, rapid and effective hemostasis. Afterwards, a careful 
observation of the forearm is required especially if the procedure is completed with the 
same initial access. 
The most common etiology of hematoma is radial or small side branch perforation by the 
guidewire during sheath insertion or loops crossing especially in patients receiving multiple 
antiplatelet therapies (85). 
Inadequate catheter manipulations or forceful maneuvers during guidewire or catheter 
advancement can also cause small radial side branch avulsions or dissections leading to 
hematomas. Hydrophilic guidewires easily entering these small arteries should always be 
advanced carefully because of their high perforation risk profiles. 
Delayed recognition of a quiet but prolonged bleeding may lead to a large hematoma 
formation and sometimes to a compartment syndrome by pressure induced occlusion of the 
two major forearm arteries (ulnar and radial) (83,86).This severe complication must be 
treated by urgent fasciotomy and hematoma drainage to prevent ischemic injuries (Fig. 4). 
Fortunately, this very infrequent complication more often occurs during the learning curve 
of the technique and can be partially avoided by adequate nursing staff education and 
training. 
4.4 Miscellaneous complications 
Radial artery eversion or rupture during sheath removal or when catheters are drawing 
back, are due to a severe and refractory spasm of the radial artery blocking material retrieval 
(87). This complication should never occur by using hydrophilic-coated sheaths/catheters 
and with gentle manipulations.  
Extremely rare cases of axillary, infraclavicular or even mediastinal hematomas due to 
perforation of a small arterial branch have also been reported (88).Late rebleeding occurring 
several hours or days after the procedure, as well as pseudo-aneurysms and arterio-venous 
fistula are quiet rare after transradial approach (see below paragraph 2.2).  
Causalgia (uncommon) is secondary to nerve injury during arterial puncture or sometimes 
secondary to aggressive haemostatic compression (50). Residual pain is often transient but 
may be permanent. Similarly, but with a more severe clinical pattern, instances of chronic 
regional pain syndrome are described at the whole arm level (89).  
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Fig. 4. Rare case of compartment syndrome (The same patient before and after urgent 
fasciotomy) 
4.5 Conclusions  
Long term consequences of radial artery occlusion or injury have to be further investigated, 
not only in patients requiring repeated percutaneous coronary interventions but also for 
patients in whom a radial conduit may be used for a surgical myocardial revascularization 
or the creation of an arterio-venous fistula. 
To defend the use of radial access for coronary interventions, the conclusions of some recent 
major trials do not advocate the superiority of the radial artery over venous conduits for 
CABG surgery in terms of usefulness as well as for short or long-term patency (90). 
Nevertheless a retrospective study has shown a reduced early graft patency (77% versus 
98%, p=0.017) in patients who had experienced a previous radial procedure before radial 
artery harvesting but without early clinical impact (91). 
5. Clinical results and outcomes with transradial approach  
5.1 Drastic reduction of periprocedural bleeding complications with transradial 
approach potentially drives reduction in mortality  
Initially based on limited observational studies, followed by small single center or limited 
multicenter randomized studies, data concerning the safety of transradial approach and the 
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lack of severe access site bleeding when compared to transfemoral approach are now 
supported by large registries (22), several meta-analyses (11,24) and more recently by a 
large, randomized and multicenter trial (2). According to these data, when compared with 
the transfemoral approach, a 27% (2) to 80% (11) reduction of entry-site bleeding 
complications may be expected with transradial approach. 
As a result of these observations and of the progressive widespread endorsement of 
guidelines related to antithrombotic therapies for coronary procedures, attention has 
progressively turned to periprocedural bleeding complications and how to reduce the risk. 
If post-PCI bleeding events not related to the arterial access site are more difficult to 
anticipate, current literature, as Rao et al. have written, provides more and more data 
suggesting that the choice of the radial rather than the femoral access is associated with 
comparatively larger reductions in bleeding risk than those ever achieved with any 
anticoagulant strategy (92).  
In parallel, according to several important studies, major bleeding events occurring after 
percutaneous coronary interventions have been shown to be independently associated with 
a marked increased risk of death and recurrent ischemic events in patients with an acute 
coronary syndrome or undergoing an elective revascularization (13,15,17,21,24,93). More 
precisely, bleeding in the 30 days after a percutaneous coronary intervention is strongly 
associated with mortality as late as 1 year after the procedure. This bleeding in the first 30 
days after the procedure is comparatively as strong as the 30-day occurrence of other events 
such as post-procedural myocardial infarction and the need for an urgent revascularization. 
Not only major but also minor bleedings have been shown to be associated with late 
mortality (15). Before these observations, the composite endpoint of efficacy and safety used 
to assess PCI procedures was, traditionally, the combined incidence of death, myocardial 
infarction and urgent repeat revascularization of the target vessel at 30-days. To take into 
account post PCI bleeding impact on mortality, the “quadruple endpoint” that includes 30-
days incidence of death, myocardial infarction, urgent revascularization and major bleeding 
has been recently introduced and should be promoted for the assessment of outcome after 
PCI. 
Finally, as expected, a link between the reduction of bleeding complications with transradial 
interventions and a potential mortality reduction had recently emerged from data analysis. 
In the MORTAL study, Chase et al. found, by data linkage of three databases collecting 
clinical and procedural outcomes of 38,872 PCI patients of the British Columbia Cardiac 
Registry, that patients treated by transradial approach had a significantly lower rate of post-
procedural blood transfusions (1.4% versus 2.8% for femoral, p<0.01) and a significant 
reduction in 30-day and 1-year mortality, odds ratio = 0.71 [95% CI 0.61 to 0.82] and 0.83 
[95% CI 0.71 to 0.98], respectively (all p<0.001). In this study, the absolute increase in risk of 
death at 1 year associated with receiving a transfusion was 6.78% and the number needed to 
treat was 14.74 (prevention of 15 transfusions required to "avoid" one death). Therefore, 
transradial approach could potentially save one life for one thousand percutaneous 
coronary interventions performed by this way rather than by transfemoral approach (22). A 
large international registry provided similar results and demonstrated that transradial 
approach was independently associated with a lower risk of death or myocardial infarction 
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after PCI (odds ratio = 0.52 [95% CI 0.31 to 0.89]) (94). Subsequently, the PRESTO ACS 
vascular substudy, including patients with non-ST-elevation acute coronary syndromes, also 
showed significant reduction in bleedings with the radial approach (0.7% versus 2.4% for 
femoral, p=0.05) and for the combined endpoint of 1-year mortality or re-infarction (4.9% 
versus 8.3%, p=0.05)(95). In patients suffering ST-segment elevation myocardial infarction 
(STEMI), the meta-analysis conducted by Vorobcsuk demonstrated a significant mortality 
reduction with transradial PCI (2.04% versus 3.06% for femoral, odds ratio= 0.54 [95% CI 
0.33-0.86], p=0.01) (96). In the meta-analysis conducted by Jolly et al., despite the 
confirmation of a dramatic reduction of major access site bleedings with the transradial 
approach (0.05% versus 2.3% for femoral, odds ratio= 0.27 [95% CI 0.16, 0.45], p < 0.001), no 
significant association between this approach and a reduced 1-year mortality was found 
(24). In the same way, in the RIVAL study including patients with acute coronary 
syndromes, radial access did not reduce the primary outcome of death, myocardial 
infarction, stroke or non-CABG-related major bleeding compared with femoral approach 
even if radial access significantly reduced vascular access complications and insured similar 
procedural success rates (but patients presented with cardiogenic shock, known severe 
peripheral vascular disease precluding a femoral approach or previous coronary bypass 
surgery using the two internal mammary artery were ineligible for this trial). Nevertheless 
when the results of the RIVAL study ,restricted to centers with the highest radial tertile in 
this study, are included in an updated meta-analysis of all randomized trials conducted by 
known radial experts, the composite of death, myocardial infarction, or stroke was lower in 
the radial group than in the femoral group (2.3% versus 3.5%, p=0.005) (2). These 
observations suggest that the effectiveness of radial access might be linked to operator’s or 
center’s expertise in transradial PCI. 
5.2 Does transradial approach influence the occurrence of silent cerebral injuries or 
post-procedural strokes?  
Stroke is also a subject that people are worried about with the radial approach but previous 
studies have never demonstrated higher rates of TIAs or strokes with this technique even if 
used in higher risk subgroups of patients, such as the octogenarians (2,24,27). 
Lund et al. and more recently Jurga et al. raised concern about the possibility that 
transradial access may induce subclinical solid cerebral microemboli at a higher extent than 
the transfemoral approach (97,98). As assessed by magnetic resonance imaging, 15% of 
patients suffered embolization toward the brain when the catheter passed from the right arm 
to the aorta in those examined with transradial access compared with none in the transfemoral 
group (p=0.567)(98). Transcranial Doppler showed that significantly more microemboli 
passed the right middle cerebral artery with right radial access than with the femoral (for 
radial median number of microemboli was 10 (1-120) and 6 (1-19) for femoral) (97). 
Nevertheless, these two small studies have to be interpreted with caution for many reasons. 
The limited number of patients, the not so well reported operators experience for transradial 
approach but also the restricted use of the right radial artery may have negatively 
influenced the results. The clinical implications of these observations and the risk of 
cognitive impairment have not been explored further. 
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5.3 What about operator and patient radiation exposure during a transradial 
approach? 
Interventional cardiology is known to be one of the professions with the greatest exposure 
to radiation. This is currently a growing problem for the cardiologist’s health. Therefore, 
data regarding transradial technique are of great interest. 
When interventional cardiologists, or fellows during their training, are dealing with a new 
technique they are often confronted with a higher level of radiation. When skills improve, 
catheter manipulations are more efficient and procedures are shortened which finally helps  
minimize radiation exposure. 
For the transradial approach the problem is the same but, being technically more 
demanding, this technique is associated with a longer learning curve. However, in current 
literature, radial access is consistently associated, when compared to femoral, with longer 
procedural and fluoroscopic times which slightly but significantly increase occupational 
radiation exposure for operators but also irradiation for patients (1,2,11,24,99). In the RIVAL 
study, median fluoroscopy time was higher in the radial group than in the femoral group 
(9.8 min versus 8.0 min, p<0.0001) and these results were similar to those reported by 
Agostoni et al. (8.9 min versus 7.8 min, p< 0.001) or Rao et al. (13.5 versus 11.3 min, 
p<0.01).Jolly et al. have reported a mean difference of 0.4 minutes of fluoroscopy between 
the two techniques ([95% CI 0.3-0.5], p<0.001). The main limitation of previous observations 
is the significant variability among operators’ performances. Some other confounding 
factors have to be discussed. 
First of all, fluoroscopy time does not always correlate well with radiation dose received by 
operators (100). Secondly, many centers used classic catheter curves (Judkins, Amplatz, etc) 
for either diagnosis or intervention but the use of a dedicated radial catheter (Optitorque 
TIG™ catheter, Terumo corp.) may have influenced total fluoroscopic time. Indeed, radial 
operators have to take advantage of the possibility to complete a full coronary and left 
ventricular study with only one catheter to reduce radiation exposure (which is a significant 
difference compared to the femoral technique). Third, the exact puncture site is not always 
clearly reported in these trials. As mentioned before, a recent randomized trial, designed to 
evaluate safety and efficacy of left radial approach compared with right radial approach for 
coronary diagnostic and interventional procedures, showed that the left side was associated 
with slight but significantly lower fluoroscopy time and radiation dose adsorbed by 
patients. The left radial access advantages were particularly seen in older patients and for 
operators in training (66). These results are encouraging and future trials may further 
explore the potential advantages of a systematic left radial approach with the use of 
dedicated radial catheters to reduce the amount of fluoroscopy and finally the gap with 
femoral approach in terms of radiation exposure. 
In addition, impact of operator ability in catheters or X-Ray tube manipulations (beam 
collimation, adequate tube angulations and operator position), as well as the use of radiation 
protection devices (low leaded flaps, upper mobile leaded glass, lead shields, lead aprons) 
are not often evaluated. The procedural setting (coronary angiography versus angioplasty, 
ad-hoc versus staged or urgent coronary interventions) may also influence measurements. 
Moreover many of these studies have been performed in centers (or by operators) with 
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limited experience in transradial approach and results have not been corrected for probable 
improvements with greater expertise. 
Finally, even if differences in terms of radiation dose beneath the lead apron are minimal 
between these approaches, their clinical impact in the long term is not known and operators 
should always apply all efforts to reduce the radiation dose in their daily practice. 
5.4 Conclusions 
Concerning many points, the debate is not closed and future randomized trials, if correctly 
powered to demonstrated differences in primary outcomes between the two vascular 
approaches and designed to avoid confounding factors, will be useful to confirm these 
findings. However, all the previous authors agree with the fact that clinicians may choose 
radial access for percutaneous coronary interventions because of its similar performances 
and above all, its reduced vascular complications. 
6. Transradial approach: The perspectives  
6.1 Outpatient strategy is feasible with transradial approach  
Ad-hoc percutaneous coronary interventions, performed immediately after diagnostic 
angiography, have been shown to have equivalent short and long term safety when 
compared to elective interventions (101-105). In current clinical practice, ad-hoc PCI 
represents the majority of elective coronary interventions in most countries. PCI programs 
with same day discharge are therefore conceivable.  
In accordance with the known benefits of transradial interventions, including less bleeding 
complications, better quality of care and earlier ambulation after the procedure, it was 
natural to test the feasibility and safety of an ambulatory discharge strategy in selected 
patients undergoing transradial coronary procedures. Numerous international studies are 
now available and even if not always randomized, they have validated this strategy after 
uncomplicated transradial percutaneous coronary interventions (106-112). No more access 
site complications are observed and the majority of events occurring 24 hours after 
discharge would not have been avoided by traditional next-day discharge. Bertrand et al. 
have also shown in a selected high risk population of patients (two thirds of patients 
presented with unstable angina and approximately 20% presented with high-risk acute 
coronary syndrome prior to the procedure) that same-day home discharge after 
uncomplicated transradial coronary stenting and administration of a bolus of abciximab is 
not clinically inferior to the standard overnight hospitalization with a bolus of abciximab 
followed by a 12-hour infusion. The primary composite end point of this study was the 30-
day incidence of any of the following events: death, myocardial infarction, urgent 
revascularization, major bleeding, repeat hospitalization, access site complications, and 
severe thrombocytopenia. The incidence of the primary end point was 20.4% in the same-
day discharge group and 18.2% in the overnight hospitalization group (P=0.017 for non-
inferiority).No death occurred and the rate of major bleeding in both groups was extremely 
low at 0.8% and 0.2%, respectively (106). 
Interestingly, similar feasibility and safety data are far less numerous to date for femoral 
approach, even if the same strategy may likewise be amenable by this access. Previous trials 
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have demonstrated a higher incidence of local vascular complications either with or without 
the use of a vascular closure device and despite an optimal post-PCI recumbency depending 
on the vascular access management strategy chosen by the operator. Moreover, patients 
undergoing a transfemoral access, even if receiving closure devices, more frequently need to 
be reassured regarding early ambulation compared to those with a transradial approach and 
an unrestricted post-catheterization ambulation (109).  
6.2 Reductions of hospitalizations stays and costs  
Several dedicated costs analyses have shown a significant reduction in hospital costs with 
transradial access compared to other arterial access sites .The economic benefits of the 
transradial approach are mainly derived from its known advantages: a reduced incidence of 
vascular access site complications and immediate ambulation after the procedure (45). 
A lower rate of access site complications also means decreased length of stay and costs 
compared with those observed in case of an adverse event (1,113,114). A vascular 
complication inevitably drives additional charges related to its careful medical evaluation 
using different diagnostic vascular imaging techniques and because of treatments required. 
Red blood cell or platelet transfusions (preceded by numerous laboratory tests), thrombin 
injections or operating room charges for surgical repair rapidly increase hospitalization 
costs. These adverse outcomes inevitably prolong hospitalization but indirect costs linked 
with an increased nursing and staff workload must also be considered even if they are more 
difficult to appreciate. Several authors have evaluated the negative economic impact of 
vascular access complications and the incremental costs ranged from $ 4000 for minor 
complications up to $ 14 000 for major events (114-116). Cooper et al. have showed, in a 
single center randomized study, that transradial access for diagnostic cardiac catheterization 
led to significant reductions in hospital costs when compared to femoral access ($ 2010 
versus $2299 respectively, p< 0.001). Lower bed costs, mainly, taking into account nursing 
workload, but also pharmacy explain the median cost reduction of 289 $ per procedure 
(117). In the same way, Roussanov et al. have shown that a femoral access with or without 
the use of a closure device also failed to reduce total hospitalization costs as compare to 
radial access even in case of similar recovery times (radial =369.5 $ ± 74.6, femoral= 446.9 $ ± 
60.2 and femoral with closure device 553.4 $ ± 81.0; p < 0.001) (118). 
Immediate ambulation, in addition to showing radial approach safety, provides additional 
cost reductions through different mechanisms. First, transradial approach provides shorter 
length of stay .A systematic review and meta-analysis of randomized trials showed that 
radial access reduced hospital stay by a mean of 0.4 days [95% CI 0.2-0.5], p=0.0001) which 
also means an expedited room turn-over (24).Secondly, as reported by Amoroso et al, 
nursing workload can be significantly reduced inside (86 min versus 174 min for femoral 
access) as well as outside the catheterization laboratory (386 min versus 720 min for femoral 
access) when the radial way is systematically used for a catheterization procedure (119).An 
increased catheterization laboratory throughput can also be expected with radial access 
because less time is spent for sheath removal. Third, it has been shown that same day home 
discharge after an uncomplicated transradial percutaneous intervention results in a 50% 
relative reduction in post-PCI medical costs. In the EASY trial, at 30-day follow-up, the 
mean cumulative medical cost per outpatient was $1,117 ± $1,554 versus $2,258 ± $1,328 for 
overnight-stay patients (Canadian dollars). The mean difference of $1,141[95% CI: $962 to 
$1,320] was mainly due to the extra night for overnight hospital stay (120). Finally, with 
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shorter length of stay and fewer vascular access site complications, a more rapid return to 
professional activities is insured for working patients. 
Dedicated radial equipments (such as micropuncture kits and catheters) are still a little bit 
more expensive than those used for femoral access. However, the RIVAL study reported the 
use of a lower mean number of diagnostic catheters per procedure with transradial access 
and similarly the same number of guiding catheters per PCI for the two techniques (2). 
Economic implications of these observations are not yet quantified, especially during the 
early adoption of the radial technique, which is often associated with increased catheter 
usage because of frequent inadequate choices.  
7. Conclusions  
Over the last two decades, major improvements have been achieved in pharmacotherapy 
and device technology making percutaneous coronary interventions safer, despite the 
increasing complexity of clinical and anatomic conditions treated during these procedures. 
Numerous trials are now available and show undoubtedly the superiority of the transradial 
approach with respect to the incidence of vascular access site complications, especially 
bleeding, and this despite the fact that all transradial procedures are performed immediately 
after an initial bolus of heparin to prevent radial artery thrombosis. Moreover, transradial 
percutaneous interventions can be performed with the same success rate as procedures by 
femoral approach and have shown their capacities to shorten hospitalization duration and 
offer the possibility for an outpatient strategy. In addition, transradial access has the 
potential of reducing medical costs and increasing hospital bed utilization without 
jeopardizing patient safety. The transradial approach also increases peri-procedural patient 
comfort and is now strongly preferred by patients for subsequent procedures (2,117). All 
these advantages are maybe a part of the solution to reduce pressure on limited hospital 
resources facing rising demands. Nevertheless, even if the transradial approach is extremely 
safe and occlusion of the artery without any clinical consequences, further studies are 
needed to search for materials minimizing physiological and anatomical changes in the 
cannulated radial artery. Radial experts underscore the need for other large randomized 
trials to confirm that radial approach has a favourable impact on the incidence of post 
procedural ischemic events and cuts mortality as compared to femoral approach. In this 
case, guidelines relative to percutaneous coronary interventions should be updated and the 
worldwide practice changed but transradial access is already an essential tool for the 
interventional cardiologist. 
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